Age, Biography and Wiki
Ian Read was born on 1953 in Forfar, Scotland, is an Ian C. Read is born business executive. Discover Ian Read's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 71 years old?
| Popular As |
N/A |
| Occupation |
Executive Chairman, Pfizer |
| Age |
71 years old |
| Zodiac Sign |
N/A |
| Born |
1953 |
| Birthday |
|
| Birthplace |
Forfar, Scotland |
| Nationality |
American
|
We recommend you to check the complete list of Famous People born on .
He is a member of famous Executive with the age 71 years old group.
Ian Read Height, Weight & Measurements
At 71 years old, Ian Read height not available right now. We will update Ian Read's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Ian Read Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Ian Read worth at the age of 71 years old? Ian Read’s income source is mostly from being a successful Executive. He is from American. We have estimated Ian Read's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Executive |
Ian Read Social Network
Timeline
Ian C. Read (born 1953) is a Scottish-born American business executive and a chartered accountant, serving as executive chairman of pharmaceutical company Pfizer.
Read received a bachelor's degree in chemical engineering from Imperial College London in 1974.
He qualified as a chartered accountant in 1978.
Read has spent his entire career with Pfizer, starting in 1978 as an operational auditor.
He worked in Latin America through 1995, holding positions ranging from CFO of Pfizer Mexico (Pfizer's largest subsidiary in Latin America) to country manager of Brazil.
In 1996, he was appointed president of the Pfizer International Pharmaceuticals Group, Latin America/Canada.
He assumed the position of executive vice president—Europe/Canada in May 2000, added the responsibilities for Africa/Middle East region as of January 2004 and responsibilities for Latin America in March 2006.
He was named vice president of Pfizer in 2001 and promoted to president of worldwide pharmaceutical operations in 2006.
He is a member of the Pfizer Leadership Team.
On 5 December 2010, when Read "took over from Jeffrey Kindler as Pfizer’s CEO, the drug firm–the world’s largest–was facing the impending patent expiration of Lipitor, the bestselling drug ever made, and the utter failure of one of the most lavishly funded research laboratories on the planet to develop much of anything."
Read is also a director of Kimberly-Clark.
Read is now an American citizen.
By October 2015 during the Drug Pricing Firestorm, Forbes journalist Matthew Herper, wrote how "Read, with his calculating mind, must get through the public’s rage over six-figure price tags for breakthrough drugs and yet keep Pfizer’s pricing power more or less intact. Doing so is absolutely critical: 34% of Pfizer’s revenue growth over the past three years has come from increasing prices on existing drugs, according to SSR, a Stamford, Conn.-based consulting firm. New medicines, especially for cancer, are selling for $100,000-plus–prices that were unimaginable five years ago."
He was succeeded as CEO by Albert Bourla on 1 January 2019, becoming executive chairman.
Read was born in Forfar, Scotland, to a Scottish mother, but his parents returned to Rhodesia (now Zimbabwe) when he was six-weeks-old, and he grew up there.
In September 2019, Pfizer announced Read would retire as executive chairman at the end of 2019, ending a four-decade career there.
Read has a holiday home near Bonita Springs, Florida.
